Differential effects of BTK inhibitors ibrutinib and zanubrutinib on NK-cell effector function in patients with mantle cell lymphoma

Flinsenberg, TWH; Tromedjo, CC; Hu, N; Liu, Y; Guo, Y; Thia, KYT; Noori, T; Song, X; Aw Yeang, HX; Tantalo, DG; Handunnetti, S; Seymour, JF; Roberts, AW; Ritchie, D; Koldej, R; Neeson, PJ; Wang, L; Trapani, JA; Tam, CS; Voskoboinik, I

Citations

Scopus

Web of Science

Altmetric

Author

Flinsenberg, TWH; Tromedjo, CC; Hu, N; Liu, Y; Guo, Y; Thia, KYT; Noori, T; Song, X; Aw Yeang, HX; Tantalo, DG; ...

Date

2020-01-31

Source Title

Haematologica: the hematology journal

Publisher

FERRATA STORTI FOUNDATION

University of Melbourne Author/s

Aw Yeang, Han Xian; Seymour, John; Ritchie, David; Neeson, Paul; Trapani, Joseph; Voskoboinik, Ilia; Roberts, Andrew; Koldej, Rachel; Tam, Constantine; Handunnetti, Sasanka

Affiliation

Sir Peter MacCallum Department of Oncology
Centre for Cancer Research
Medicine (RMH)
Medicine (St Vincent's)

Metadata

Show full item record

Document Type

Journal Article

Citations

Flinsenberg, T. W. H., Tromedjo, C. C., Hu, N., Liu, Y., Guo, Y., Thia, K. Y. T., Noori, T., Song, X., Aw Yeang, H. X., Tantalo, D. G., Handunnetti, S., Seymour, J. F., Roberts, A. W., Ritchie, D., Koldej, R., Neeson, P. J., Wang, L., Trapani, J. A., Tam, C. S. & Voskoboinik, I. (2020). Differential effects of BTK inhibitors ibrutinib and zanubrutinib on NK-cell effector function in patients with mantle cell lymphoma. HAEMATOLOGICA, 105 (2), pp.E76-E79. https://doi.org/10.3324/haematol.2019.220590.

Access Status

Access this item via the Open Access location